Add 2 More Reports For 20% off

Report Overview

Chronic insomnia disorder is reported to affect 1 in 10 people, with the prevalence considerably higher in the older population. As per a review published in the Current Geriatrics Reports, up to 75% of older adults suffer from insomnia symptoms, and one-fifth of them are prescribed sleep medications. Unlike acute insomnia, chronic insomnia can severely impact daily functioning and overall well-being. Over time, it can also increase the risk of developing conditions like high blood pressure, heart disease, diabetes, and mental health disorders.

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Chronic Insomnia Epidemiology Forecast Report Coverage

Expert Market Research's “Chronic Insomnia Epidemiology Forecast Report 2032’’ offers comprehensive information on the prevalence and demographics of chronic insomnia. It projects the future incidence and prevalence rates of chronic insomnia across various populations. The study covers age, gender, and type as major determinants of the chronic insomnia-affected population. The report highlights patterns in the prevalence of chronic insomnia over time and projects future trends based on multiple variables. The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of chronic insomnia in the 8 major markets, namely, the United States, EU-4 (Germany, Spain, Italy, France), the United Kingdom, Japan, and India.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of chronic insomnia in the 8 major markets.

Regions Covered

  • The United States
  • EU-4 (Germany, France, Italy, Spain) and the United Kingdom
  • Japan
  • India

Chronic Insomnia: Disease Overview

Chronic insomnia is defined as a sleep disorder where the affected patient experiences difficulty sleeping for at least three nights a week for three or more months. This long-term insomnia causes daytime sleepiness and irritability and can also affect memory and concentration. It is also reported that people suffering from chronic insomnia have a higher risk of developing diabetes, high blood pressure, substance abuse, depression, and other health problems.

Chronic Insomnia: Treatment Overview

Various studies indicate that around one-fifth of older adults are prescribed sleep medications. Common prescription drugs for chronic insomnia include benzodiazepine receptor agonists (estazolam, lorazepam, and temazepam), nonbenzodiazepine receptor agonists (eszopiclone (Lunesta) and zaleplon (Sonata)), and melatonin receptor agonists, among others. Antidepressants are sometimes prescribed to patients off-label for the treatment of this sleep disorder. Although medications are available, cognitive behavioral therapy for insomnia (CBT-I) still forms the first-line treatment for chronic insomnia as it can help the patients address negative thoughts and behaviors related to sleep.

Epidemiology

The chronic insomnia epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for chronic insomnia by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for chronic insomnia and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

  • Around 10% of the population is affected by chronic insomnia disorder, which occurs at least 3 times a week in a span of at least 3 months, according to the American Academy of Sleep Medicine (AASM).
  • A review published in the Journal of Clinical Sleep Medicine (2018) states that chronic insomnia is common among older adults, with the overall prevalence of insomnia symptoms ranging from 30% to 48% in this age group.
  • A recent survey by the American Academy of Sleep Medicine in 2024 revealed that 12% of Americans are diagnosed with chronic insomnia.
  • As per Chiba, Takuyo et al. (2023), the prevalence of chronic insomnia was 24.89% in Japanese emergency professionals, with stress and long working hours being the associated factors contributing to the surge in the number of such cases.

Country-wise Chronic Insomnia Epidemiology

The chronic insomnia epidemiology data and findings for the United States, EU-4 (Germany, Spain, Italy, France), the United Kingdom, Japan, and India are also provided in the epidemiology section.

Several factors such as work patterns, availability of sleep specialists, and socioeconomic variables, among others, impact the prevalence of chronic insomnia in different regions. Urbanization, stress, and rising cases of mental disorders are increasingly contributing to the growing burden of chronic insomnia. In India, one in four people (25.7% of the population) are estimated to be affected by insomnia, with a significant proportion of them developing chronic insomnia.

Country Specific Stats:

Country

Prevalence (%)

United States

12% of the population

United Kingdom

XX

Germany

XX

Italy

XX

France

XX

Spain

XX

Japan

XX

India

XX

Scope of the Report

  • The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of chronic insomnia based on several factors.
  • Chronic Insomnia Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India)
  • The report helps to identify the patient population, the unmet needs of chronic insomnia are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

  • What are the key findings of chronic insomnia epidemiology in 8MM?
  • What will be the total number of patients with chronic insomnia across the 8MM during the forecast period 2024-2032?
  • What was the country-wise prevalence of chronic insomnia in the 8 major markets in the historical period 2017-2023?
  • Which country will have the highest number of chronic insomnia patients during the forecast period of 2024-2032?
  • Which key factors would influence the shift in the patient population of chronic insomnia during the forecast period of 2024-2032?
  • What are the currently available treatments for chronic insomnia?
  • What are the disease risks, signs, symptoms, and unmet needs of chronic insomnia?

Related Reports

Global Sleep Apnea Devices Market

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Report Summary

Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.

Key Highlights of the Report

Please note that the figures mentioned in the description serve as estimates and may vary from the actual figures presented in the final report.

Report Features

Details

Base Year

2023

Historical Period

2017-2023

Forecast Period

2024-2032

Epidemiology Statistics Provided

  • Diagnosed Prevalent Cases
  • Type-Specific Cases
  • Gender-Specific Cases
  • Age-Specific Cases

Segmentation Provided

  • Epidemiology by Age group
  • Epidemiology by Gender
  • Epidemiology by Type of Disease
  • Epidemiology by Region

Geographies Covered

  • United States
  • United Kingdom
  • Germany
  • Italy
  • France
  • Spain
  • Japan
  • India

Purchase Full Report

Datasheet

 

USD 2,199

USD 1,869

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 3,299

USD 2,799

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 4,399

USD 3,699

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 5,499

USD 4,699

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63-287-899-028, +63-967-048-3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63-287-899-028, +63-967-048-3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124